Looking forward to meeting GAiT members at the annual @NYSCF meeting http://www.nyscf.org/events
The iPSC Quality Assessment Round Data Manuscript has been sent to all Authors for final review. Please check your inboxes. We shall submit the manuscript after responding to final questions and comments.
The iPSC Quality Assessment Round Manuscript is to be circulated to all authors tomorrow for final review & edit before submission. Authors will have two weeks to review. Well done to all Organizers and Participants for getting this far, especially with all the COVID disruption.
Excellent line up for this year's virtual @nyscf
conference hosted by GAiT Director @SusanNYSCF
The NYSCF Conference - New York Stem Cell Foundation
The NYSCF Conference is the leading scientific meeting on translational stem cell research. It...
Did you know? GAiT's Industry Liaison Committee is co-chaired by @CiRA_F_J pediatric oncologist Dr. Noriko Shimasaki and @CCRM_ca President/CEO and GAiT Director Dr @MichaelMay5. The Committee focuses on accelerating iPSC therapies to the clinic.
GAiT members are hoping to see each other in person at Phacilitate Advanced Therapies Week in Miami. Register at https://www.advancedtherapiesweek.com/welcome
How registries and manufacturers/developers can work together effectively to accelerate cell therapies was discussed at the WMDA CGT webinar this morning. Material procurement is currently a key issue for manufacturers and this includes suitable donor material.
GAiT is sad to hear of the passing of Dr Wen Bo Wang. Our deepest condolences to her family and friends. May She rest in peace.
Wen Bo Wang Obituary - Oceanside, CA
Celebrate the life of Wen Bo Wang, leave a kind word or memory and get funeral service information care of Ete...
iPSC translation e-book developed by @regenmed and @biotechne https://resources.bio-techne.com/bio-techne-assets/images/literature/RMN_Bio-Techne_iPSCs_eBook.pdf?utm_medium=paidsocial&utm_source=linkedin&utm_campaign=BT-08-2021-CGTBU-iPSC-eBook_B
Scaling-up pluripotent stem cell (PSC) culture is not simply about “numbering” up. Scale-up is a technique that requires expertise and careful planning. Read the latest CDMO Education Centre post to learn more. https://cdmo.ccrm.ca/blog/scaling-up-production-of-pluripotent-stem-cells-part-1-begin-with-the-end-in-mind-0
“Universal cells: a great solution...to what problem?“ with @enhancerleo, @peretzp, Megan Sykes, @cplanetas, Stephen Sullivan. Sat, 26 Jun at 20:00 on @clubhouse!
Universal cells: a great solution...to what problem? - DESIGNER IMMUNOLOGY
Saturday, June 26 at 12:00pm PDT with Leonardo Ferreira, Peretz Partensky, Megan Sykes, Torsten Meissner, Stephen Sull...
Today's episode is out!
Dr. Stephen Sullivan from the Global Alliance for @iPSCTherapies (GAiT) joins us to discuss the importance of quality in cell therapy products, and how international cooperation can help move therapies from the lab to the clinic.
The CiRA Foundation @CiRA_F_J and
@CCRM_ca will co-chair GAiT's Industry Liaison Committee. This Committee will focus on clarifying the translation roadmap for iPSC therapeutics and how to improve efficiencies.
We pay tribute to the participants of the first iPSC Quality Assessment Round in the Stem Cell Podcast recorded today and look forward to its broadcast on in two weeks time.
The Stem Cell Podcast
Culturing knowledge in stem cell research.
Great interview of Stephen Sullivan, International Liaison Officer at the GAiT @IPSCtherapies a global initiative to support the clinical application of iPSC-based therapies, funded by @nyscf @CGTCatapult @CCRM_ca @Inserm and led by a prestigious scientific advisory board! https://twitter.com/FeyeuxMaxime/status/1397521579366625282
A poll has been sent to Industry Members' emails to schedule the first Industry Liaison Committee Meeting in the coming weeks.
#ISCT2021 Breaking News – ISCT and WHO launch CGT nomenclature standards at ISCT 2021!
Find out more: https://mailchi.mp/isctglobal/te-rmplenary-6252360
We shall be updating Participants of the iPSC Quality Assessment Round on the manuscript shortly. A professional statistician re-analysed the amalgamated dataset to fortify the paper.
GAiT is also planning its first Industry Liaisons committee meeting. Internal discussions with GAiT Director / CCRM President & CEO Michael May, to discuss schedule, materials, and format, will take place this week. GAiT will then reach out to Industry members directly.